Proud sponsor of
JUST WON’T QUIT. THIS ITCH
APOQUEL® can help! Prescription APOQUEL® (oclacitinib tablet) has been prescribed for more than 6 million dogs.1
APOQUEL works differently than other treatments. It stops allergic itch at the source and starts providing relief in as little as 4 hours, with control of itch within 24 hours.2,3 Plus, APOQUEL is not a steroid. Y
for long-term maintenance therapy.4 See how this revolutionary prescription medicine can help your itchy dog! Ask your veterinarian about APOQUEL today.
arian about APOQUEL today Learn more at
ApoquelDogs.com. INDICATIONS ATIONS
Contr ol of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
IMPORTANT SAFETY INFORMATION ANT SAFE ETY INFORMA ATION
Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chancesof developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse.
It’s fast itch relief. Pa relief. Paws down.
APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.
Please see Brief Summary of Pr escribing Information on following page. Refer ences: 1. Data on file, 2019. Zoetis Services LLC. 2. G d
Gadeyne C, Little P Ki VL Ed (Apoquel C Littl P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib and quality of life. Vet
®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol . 2014;25(6):512-518, e86. doi: 10.1111/vde.12166. 3. Cosgrove SB, W ren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114. doi: 10.1111/vde.12047. 4. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety , efficacyove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety et Dermatol. 2015;26(3):171-179, e35.
ol of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. et Derm
All trademarks are the property of Zoetis Ser vices LLC or a related company or a licensor unless other © 2019 Zoetis Ser
© 2019 Zoetis Services LLC. All rights reserved. APQ-00457R1
www.TheNewBarker.com THE NEW BARKER 19 vices LLC or a related company or a licensor unless otherwise noted. y. You can even use APOQUEL ®
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
